Recap: Albireo Pharma Q2 Earnings

Albireo Pharma ALBO reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Albireo Pharma missed estimated earnings by 23.64%, reporting an EPS of $-2.04 versus an estimate of $-1.65.

Revenue was up $5.78 million from the same period last year.

Last quarter the company missed on EPS by $0.34 which was followed by a 18.37% drop in the share price the next day.

Here's a look at Albireo Pharma's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-1.85	-1.35	-0.38	-1.96
EPS Actual	-2.19	-0.57	-2.03	-1.90
Revenue Estimate	7.96M	12.48M	3.48M	1.98M
Revenue Actual	6.83M	32.52M	3.66M	2.43M

To track all earnings releases for Albireo Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.